Orthostatic Hypotension Clinical Trials 2023

Orthostatic Hypotension Clinical Trials 2023

Orthostatic Hypotension research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in orthostatic hypotension clinical trials today.

Orthostatic Hypotension Clinical Trials

Here are the 6 most popular medical studies for orthostatic hypotension

Popular filter options for orthostatic hypotension trials

Multiple System Atrophy Clinical Trials

View 9 Multiple System Atrophy medical studies.

MSA Clinical Trials

View 9 MSA medical studies.

Orthostatic Hypotension Clinical Trials With No Placebo

View 24 orthostatic hypotension medical studies that do not have a placebo group.

View More Orthostatic Hypotension Trials

See another 6 medical studies focused on orthostatic hypotension.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to orthostatic hypotension

What are the top hospitals conducting orthostatic hypotension research?

When it comes to cutting-edge clinical trials in the field of orthostatic hypotension, several hospitals are making significant strides. One standout institution is the Autonomic Dysfunction Center at Vanderbilt University Medical Center in Nashville. With four active trials focused on orthostatic hypotension and a total of four completed studies to date, this center has been dedicated to understanding and treating this condition since their first trial recorded in 2016. Another notable hospital is located at the University of Calgary in Canada's picturesque city of Calgary. This facility currently has three ongoing orthostatic hypotension trials and an impressive history of six past studies, with their earliest recorded trial dating back to 2008.

Meanwhile, Vanderbilt University itself plays a vital role as well, conducting three active orthostatic hypotension trials alongside ten accomplished investigations overall since their pioneering study commenced in 1996—a testament to their dedication over the years. In West Orange, New jersey, the Kessler Foundation focuses on advancing knowledge about this condition through two ongoing clinical trials while having just started its journey with orthostatic hypotension research during2023.Despite being relatively new to the scene Quality Living Inc., based out Omaha is also contributing towards tackling Orthostatic Hypertention as they hold one current investigation upon which they embarked only recently starting from 2021.

These top hospitals exemplify unwavering commitment when it comes to studying and finding solutions for individuals living with orthostatic hypotension—an often debilitating condition that causes low blood pressure upon standing up suddenly or remaining upright for extended periods. Through these collaborative efforts across different locations globally,researchers aim not only provide relief but improve quality life for countless individuals impacted by this medical issue worldwide

Which are the best cities for orthostatic hypotension clinical trials?

When it comes to orthostatic hypotension clinical trials, several cities are at the forefront of research and development. Nashville, Tennessee leads with 8 active trials exploring interventions such as accelerometers, automated abdominal binders, and heating pads. Calgary, Alberta follows closely behind with 3 ongoing studies focused on innovative approaches like sequential gas delivery and targeted epidural spinal stimulation. Lastly, West Orange in New jersey and Omaha in Nebraska each have 2 active trials investigating optimal stimulation for blood pressure response and functional electrical stimulation respectively. These cities provide individuals with orthostatic hypotension access to cutting-edge clinical trials that aim to improve understanding and treatment options for this condition.

Which are the top treatments for orthostatic hypotension being explored in clinical trials?

Researchers are actively exploring various treatments for orthostatic hypotension in clinical trials. Some of the top contenders include:

  • Sequential Gas Delivery: This innovative approach is being tested in one active trial and marks a significant development in managing orthostatic hypotension.
  • Accelerometer: Another promising treatment, currently under investigation in one ongoing trial, utilizes an accelerometer to aid in addressing orthostatic hypotension.
  • Functional electrical stimulation (FES): FES has demonstrated potential as a therapeutic option for this condition and is undergoing evaluation through one active clinical trial.

These cutting-edge interventions hold promise for alleviating the symptoms of orthostatic hypotension and improving patients' quality of life.

What are the most recent clinical trials for orthostatic hypotension?

Recent clinical trials have been investigating potential treatments for orthostatic hypotension, a condition characterized by low blood pressure upon standing. One trial focused on a treatment group specifically targeting orthostatic hypotension patients in Phase 2, offering promise for improved management of the condition. Another study explored the use of an automated abdominal binder to alleviate symptoms, with both Phase 1 and Phase 2 showing encouraging results. Additionally, droxidopa was evaluated in Phase 1 as a potential therapeutic option for orthostatic hypotension. These ongoing trials highlight the dedication towards finding effective interventions to enhance the lives of individuals living with this challenging condition.

What orthostatic hypotension clinical trials were recently completed?

A recent clinical trial investigating orthostatic hypotension has reached a significant milestone, shedding light on potential advancements in its treatment. In December 2020, Brigham and Women's Hospital completed their trial evaluating the effectiveness of [F-18]PBR06. This innovative study serves as an important step forward in understanding and addressing the challenges posed by orthostatic hypotension. These findings offer hope for individuals grappling with this condition and provide valuable insights for future research endeavors aimed at improving patient outcomes.